Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsConcord drugs

    Concord Drugs

    Jump to

    • Concord Drugs Consolidated September 2025 Net Sales at Rs 10.28 crore, down 16.86% Y-o-Y

    • Concord Drugs Standalone September 2025 Net Sales at Rs 10.07 crore, down 14.93% Y-o-Y

    • Concord Drugs Standalone June 2025 Net Sales at Rs 13.38 crore, up 110.66% Y-o-Y

    • Concord Drugs Standalone March 2025 Net Sales at Rs 7.96 crore, down 44.95% Y-o-Y

    • Concord Drugs Standalone December 2024 Net Sales at Rs 10.77 crore, down 14.66% Y-o-Y

    • Concord Drugs Consolidated September 2024 Net Sales at Rs 12.36 crore, up 64.44% Y-o-Y

    • Concord Drugs Standalone September 2024 Net Sales at Rs 11.84 crore, up 60.4% Y-o-Y

    • Concord Drugs Consolidated June 2024 Net Sales at Rs 11.69 crore, up 30.19% Y-o-Y

    • Concord Drugs Standalone June 2024 Net Sales at Rs 6.35 crore, down 27.71% Y-o-Y

    • Concord Drugs Standalone March 2024 Net Sales at Rs 14.47 crore, up 25.35% Y-o-Y

    • Concord Drugs Standalone December 2023 Net Sales at Rs 12.62 crore, down 6.67% Y-o-Y

    • Concord Drugs Consolidated September 2023 Net Sales at Rs 7.52 crore, down 45.2% Y-o-Y

    • Concord Drugs Standalone September 2023 Net Sales at Rs 7.38 crore, down 46.18% Y-o-Y

    • Concord Drugs Standalone June 2023 Net Sales at Rs 8.79 crore, down 29.87% Y-o-Y

    • Concord Drugs Standalone December 2022 Net Sales at Rs 13.53 crore, up 0.64% Y-o-Y

    • Concord Drugs Standalone September 2022 Net Sales at Rs 13.72 crore, up 39.12% Y-o-Y

    • Concord Drugs Standalone March 2022 Net Sales at Rs 15.46 crore, up 85.29% Y-o-Y

    • Concord Drugs Standalone December 2021 Net Sales at Rs 13.44 crore, up 63.11% Y-o-Y

    • Concord Drugs Standalone September 2021 Net Sales at Rs 9.86 crore, down 40.49% Y-o-Y

    • Concord Drugs Standalone March 2020 Net Sales at Rs 13.03 crore, down 9.18% Y-o-Y

    • Concord Drugs Standalone September 2018 Net Sales at Rs 11.49 crore, up 205.04% Y-o-Y

    • Top 100 cos created Rs 28 lakh cr wealth in past 5 years: Study

      Country's top 100 companies in terms of market valuation have generated Rs 28.4 lakh crore wealth in the last five years, with Tata Group firm TCS retaining the numero uno position in the chart, says a latest study.

    • Here are a few stocks to keep an eye on August 10

      Stocks expected to gain are Sundram Fast, J&K Bank, Adani Ports, Aptech, PFC, Jubilant Life, Natco Pharma, Nitesh Estates, Globus Spirits and Emco, while stocks expected to be under pressure are Lupin, United Bank, Uco Bank, IOB, JK Tyre, Concor, Patel Integrated, Anuh Pharma, Gokaldas Exports, Kennametal, Indag Rubber, Huhtamaki PPL.

    • Concord Drugs standalone Dec '15 sales at Rs 13.37 crore

      Concord Drugs has reported a sales total income from operations of Rs 13.37 crore and a net profit of Rs 1.87 crore for the quarter ended Dec '15

    • Here are top 10 stocks to focus on January 27

      The stocks that are expected to gain are Nilkamal, HMVL, Vardaman Textiles, Bajaj Auto, OK Play India, Thangamayil Jewellery, Rajratan Wire and the stocks that will likely be under pressure include Kaya, Concor, HCL Infosystems, Vaibhav Global, Asahi Songwon, Indosolar, Scooters India, Automotive Stamping and Parrys Sugar.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347